Invention Grant
![N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists](/docs/US/2018-06-05/US09987274B2/abs.jpg.600x600.jpg)
- Patent Title: N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists
-
Application No.: US15371600Application Date: 2016-12-07
-
Publication No.: US09987274B2Publication Date: 2018-06-05
- Inventor: Hamid Hoveyda , Guillaume Dutheuil , Graeme Fraser
- Applicant: OGEDA SA
- Applicant Address: BE Charleroi
- Assignee: OGEDA SA
- Current Assignee: OGEDA SA
- Current Assignee Address: BE Charleroi
- Agency: Young & Thompson
- Priority: EP13161863 20130329; EP13193025 20131115; EP14154303 20140207
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K31/4985
![N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists](/abs-image/US/2018/06/05/US09987274B2/abs.jpg.150x150.jpg)
Abstract:
A method for treating and/or preventing hot flashes, by administering, to a patient in need thereof, of a pharmaceutically effective amount of a compound of Formula I or a pharmaceutically acceptable solvate thereof.
Public/Granted literature
Information query
